 |
|
|
Arielle D. Stanford, M.D.
Assistant in Clinical Psychiatry
Assistant Professor of Clinical Psychiatry,
Columbia University
Assistant Attending Psychiatrist,
New Yorkk Presbyterian Hospital
Research Scientist,
New York State Psychiatric Institute
|
|
|
|
|
|
|
|
|
Dr. Stanford is Assistant Professor of Clinical Psychiatry at Columbia University College of Physicians and Surgeons, in the Division of Brain Stimulation and Therapeutic Modulation where she has served as a lecturer, instructor, and mentor in psychiatry courses and residency training. She is also a Research Psychiatrist in the Division of Brain Stimulation and Therapeutic Modulation at New York State Psychiatric Institute, which focuses on the use of emerging electromagnetic means of modulating brain function to study and treat psychiatric disorders. These techniques include transcranial magnetic stimulation (TMS), vagus nerve stimulation (VNS), magnetic seizure therapy (MST), deep brain stimulation (DBS), transcranial direct current stimulation (tDCS), and electroconvulsive therapy (ECT). Dr. Stanford is currently principal investigator on a major grant supported by the National Institute of Mental Health (NIMH), the Dana Foundation, and the National Alliance for Research in Schizophrenia and Depression (NARSAD). She is actively pursuing research in the treatment and pathophysiology of schizophrenia, with particular respect to negative symptoms and social deficits in this patient population.
Dr. Stanford has authored or co-authored articles, chapters, reviews and editorials concerning schizophrenia, social cognition, and transcranial magnetic stimulation. Her work has been published in Schizophrenia Research, Biological Psychiatry, and Neurology, among others. She also does peer reviewing of submissions to the American Journal of Psychiatry, Biological Psychiatry, International Journal of Geriatric Psychiatry, Neuropsychopharmacology, Psychiatry Research, and Schizophrenia Research.
Dr. Stanford is an active member of several professional societies, including the American Psychiatric Association, the Association of Women Psychiatrists, the Association for Convulsive Therapy, and the Society of Biological Psychiatry. She is also the recipient of more than twenty honors and awards, including a Howard Hughes Research Fellowship Award, Janssen Translational Neuroscience Research Fellowship Award, NIMH K23 Career Development Award, and National Alliance for Research in Schizophrenia and Depression Brian Bass Young Investigator Award.
Brain Behavior Clinic (BBC)
|
 |
Undergraduate: Brown University, Sc.B., 1989-1993
Medical School: Washington University School of Medicine, MD, 1994-99
Internship: Columbia University/New York Presbyterian Hospital, NYSPI and Creedmoor Psychiatric Center, Internal Medicine, Neurology, Psychiatry, 1999-2000
Residency: Columbia University/New York Presbyterian Hospital/NYSPI, Psychiatry, 2000-2003
Fellowship: Columbia University/NYSPI, Schizophrenia Clinica Research Fellowship, 2003-2006
Post-Graduate: Columbia University/NYSPI, Paul Janssen Translational Neuroscience Research Award, 2006
Board Certifications: American Board of Psychiatry and Neurology
Diplomate in Psychiatry
|
 |
• Schizophrenia and Neuropsychiatry
• Brain Stimulation (Transcranial Magnetic Stimulation, Electroconvulsive Therapy and others)
|
 |
Address:
NYS Psychiatric Institute
Room 5100C Unit/Box:21
1051 Riverside Drive
New York, NY 10032
Phone: 212-543-1339
Fax: 212-543-6203
BBClinic@columbia.edu
Personal Homepage
|
 |
| Dr. Stanford is studying the pathophysiology of negative symptoms in order to develop non-pharmacological interventions to treat these disabling symptoms of schizophrenia.
|
 |
1. Stanford AD, Sharif Z, Corcoran C, Urban, N, Malaspina D, Lisanby SH : rTMS Strategies for the Study and Treatment of Schizophrenia: A Review. International Journal of Neuropsychopharmacology 2008;11(4): 563-76
2. Luber B, Stanford AD, Bulow P, Nguyen T, Rakitin BC, Haybeck C, Basner, R, Stern Y, Lisanby SH: Remediation of sleep-deprivation induced working memory impairment with fMRI-guided Transcranial Magnetic Stimulation: Testing the role of neural reserve-associated cortical networks. . Cerebral Cortex 2008;18(9): 2077-85
3. Luber, B, Stanford, AD, Malaspina, D, Lisanby, SH: Revisiting the Backward Masking Deficit in Schizophrenia: Individual Differences in Performance and Modeling With TMS. . Biological Psychiatry 2007;62(7): 793-799
4. Hoffman, RE, Stanford, AD: Transcranial magnetic stimulation clinical trials involving patients with schizophrenia. Oxford Handbook of transcranial magnetic stimulation., Ed E Wassermann, C Epstein, U Ziemann, V Walsh, T Paus and S Lisanby, Oxford University Press, Oxford, , UK, in press
5. Stanford, AD, Corcoran, C, Malaspina, D: Schizophrenia. Merritt’s Neurology, ed. Rowland, LP. Lippincott, Williams & Wilkins, Philadelphia, PA, USA, 2005
|
 |
|
FACULTY ONLY
|
|
|
